JAM
WST icon

Jupiter Asset Management’s West Pharmaceutical WST Stock Holding History

Jupiter Asset Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-159,380
Closed -$37.5M – 512
2022
Q4 		$37.5M Buy
159,380
+38,256
+32% +$9.07M 0.55% 49
2022
Q3 		$29.8M Buy
121,124
+34,942
+41% +$10.6M 0.46% 57
2022
Q2 		$26.1M Buy
86,182
+17,429
+25% +$5.67M 0.37% 77
2022
Q1 		$28.2M Sell
68,753
-45,432
-40% -$17.8M 0.34% 93
2021
Q4 		$53.8M Buy
114,185
+30,324
+36% +$13.1M 0.59% 41
2021
Q3 		$35.6M Buy
83,861
+64,328
+329% +$27.1M 0.4% 82
2021
Q2 		$7.01M Buy
19,533
+2,926
+18% +$967K 0.07% 242
2021
Q1 		$4.68M Buy
16,607
+5,714
+52% +$1.64M 0.05% 328
2020
Q4 		$3.08M Sell
10,893
-2,220
-17% -$623K 0.03% 379
2020
Q3 		$3.6M Buy
+13,113
New +$3.47M 0.04% 343

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jupiter Asset Management's WST Position: Q1 2023 in Review

Jupiter Asset Management sold out of West Pharmaceutical (WST) in Q1 2023, closing a stake of 159,380 shares — an estimated $37.5M sold.

Jupiter Asset Management first reported a position in WST in Q3 2020 and held it in 10 quarters. The position peaked at $53.8M in Q4 2021. 696 funds tracked by Wall St. Rank hold WST as of Q1 2023.

  • Jupiter Asset Management reported no remaining West Pharmaceutical position as of Q1 2023 after selling out during the quarter.
  • Jupiter Asset Management sold 159,380 West Pharmaceutical shares in Q1 2023, an estimated $37.5M.
  • Jupiter Asset Management first reported a position in West Pharmaceutical in Q3 2020 and held it in 10 quarters.
  • Jupiter Asset Management's West Pharmaceutical position peaked at $53.8M in Q4 2021.
  • 696 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2023.

Based on Jupiter Asset Management's 13F filing for Q1 2023, filed 10 May 2023.